Ladenburg Thalmann Maintains Buy on Hercules Capital, Lowers Price Target to $20
Hercules Capital (NYSE:HTGC) Posts Inline Q2 Results, Shares Rise Slightly
Hercules Capital Q2 EPS $0.50 Beats $0.49 Estimate, Sales $149.114M Beat $145.478M Estimate
Hercules Capital (HTGC) Stock Dips While Market Gains: Key Facts
How Investors May Respond To Hercules Capital (HTGC) ESOP Equity Shelf And Potential Dilution Risk
4DMT Secures Strategic Credit Facility for up to $200 Million from Hercules Capital
Hercules Capital (HTGC) Advances While Market Declines: Some Information for Investors
Brokers Suggest Investing in Hercules Capital (HTGC): Read This Before Placing a Bet
Hercules Capital: This 12% Yield Is My Top Pick For The Back Half
2 Reasons to Avoid HTGC and 1 Stock to Buy Instead
Hercules Capital Faces Its Own 12 Labors
Dyne Therapeutics Announces Expanded Debt Facility of Up To $400 Million with Hercules Capital, Inc.
Hercules Capital (HTGC) Ascends While Market Falls: Some Facts to Note
Beren Therapeutics Secures $300M In Combined Financing With Hercules Capital To Support Investments In Commercial Readiness Activities For Adrabetadex Ahead Of November 17 PDUFA Target Action Date
Hercules Capital: Attractive Valuation And Growth Potential
Hercules Capital (HTGC) Stock Moves -1.86%: What You Should Know
Is Hercules Capital (HTGC) Now Priced Attractive After Recent Share Price Weakness
Hercules Capital (HTGC) Down 7.4% Since Last Earnings Report: Can It Rebound?
Volatility, lower venture valuations drive record Q1 originations – Hercules Capital
Specialty Finance Stocks Q1 Teardown: Hercules Capital (NYSE:HTGC) Vs The Rest
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.